Fresh perspectives: Social Research on Anti-Microbial Resistance (AMR)

Summary This event will bring together researchers who are attending to ‘the social’ in AMR, including anthropologists, sociologists, historians, geographers, artists, philosophers and other related scholars. While many are engaged in productive interdisciplinary work within their every day research, this symposium presents an opportunity for concentration on disciplinary work within the social sciences and humanities. […]

Seminar | The Challenges of Estimating the Burden of AMR

Summary Antimicrobial resistance is widely recognised to be a major threat to global health, but the current burden of disease is difficult to quantify. Estimation of mortality from AMR is needed at national and global levels to inform healthcare providers and policy makers, who need an evidence base for prioritisation of interventions. Underlying challenges to […]

PhD Upgrade | Managing everyday fever: an ethnographic study of antibiotic use in Harare, Zimbabwe

Speaker Salome, LSHTM is a Zimbabwean PhD student funded by the Febrile Illness Evaluation in a Broad Range of Endemicities research project. She has been carrying out social research in Zimbabwe for more than ten years and is based with the  Biomedical Research and Training Institute (BRTI) in Harare.   Abstract Amidst rising concerns of antimicrobial resistance […]

Seminar | A sociology of antimicrobial mis-use and resistance

Summary In the search for solutions to the global problem of antimicrobial resistance, there has been a tendency to focus on ‘how’ we should behave differently (e.g. be more judicious, follow guidelines for best practice) rather than developing a deeper understanding of ‘why’ we act in the ways we do in relation to antimicrobials. In […]

LMPC Meeting | Exploiting parasite weaknesses and drug resistance

London Molecular Parasitology Club Meeting Details Speaker: Terry Smith, University of St Andrews, UK Title: Exploiting parasite weaknesses in lipid and associated metabolism   Speaker: Marcus Lee, Wellcome Sanger Institute, UK Title: Exploiting drug resistance to identify antimalarial targets   Date: 27 June 2018 Time: 18:00 Venue: John Snow Lecture Theatre, Keppel Street

Pathogen Molecular Biology Seminar | Discovery of Bedaquiline – New drug for drug-resistant Tuberculosis

Co-hosted by the AMR and TB Centre Details Speaker: Dr Anil Koul, Department of Antimicrobial Research Janssen R&D, Belgium Chair: Prof Brendan Wren Date: 25 June 2018 Time: 12:45 pm Venue: John Snow Lecture Theatre, Keppel Street

Seminar | Klebsiella pneumoniae population dynamics and antimicrobial resistance

Summary Dr Heinz’ current work focuses on gram-negative bacterial (opportunistic) pathogens; to understand how antimicrobial resistance spreads via mobile elements as well as repeated independent acquisitions of intrinsic mechanisms through changes in the chromosome, and what impact the resistance mechanisms have on the bacterial cell beyond protection from antimicrobials. Part of her work also focuses […]

Workshop | RESIST: Do we know enough for antibiotic resistance modelling to inform decision-making? 

Co-hosted between the AMR Centre and CMMID       Summary RESIST is a workshop to discuss this question in the context of the ever growing research and policy interest in tackling the spread of antibiotic resistance. We have an exciting programme of speakers from the modelling community, alongside policymakers, clinicians and experimentalists. Registration is […]

Seminar | Preemptive diagnosis, anticipatory prescribing and antimicrobial resistance in urban South Africa

LSHTM Medical Anthropology seminar Summary Abstract: Drawing on interview and observational data from public health centres and private primary care surgeries in Johannesburg, Lenore explores local ideas of immunity, resistance and stewardship, and how these influence prescribing practice and the use of common medication. She suggests that health providers operate in a subjunctive mode, making decisions […]

Seminar | Redefining susceptibility and resistance to anti-tuberculosis drugs

Co-hosted between the AMR and TB Centre Summary Redefining susceptibility and resistance to anti-tuberculosis drugs Traditionally, the World Health Organization (WHO) had relied on expert opinion to set breakpoints for phenotypic drug-susceptibility testing (DST) for the Mycobacterium tuberculosis complex, the causative agent of tuberculosis (TB). However, the evidence had been mounting that some of these […]